Danish drugmaker Novo Nordisk has launched its popular diabetes drug Ozempic in India. This move aims to capture a significant share of the growing market for diabetes and weight-loss treatments. India's large population with type 2 diabetes and rising obesity rates make it a key focus. Analysts predict the global weight-loss market could reach $150 billion annually by 2030.

See Full Page